Home
Companies
Abbott
Clinical Trials

Clinical Trials Related to Abbott

Related studies linked through entity extraction aliases.

A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease

Status: COMPLETED
Phase: PHASE3

Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up

Status: COMPLETED
Phase: N/A

EARNEST Rifabutin Pharmacokinetics (PK) Substudy

Status: UNKNOWN
Phase: PHASE2

An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid Arthritis

Status: COMPLETED
Phase: NA

Catheter Outcomes With Sternotomy Cardiac Operated

Status: COMPLETED
Phase: PHASE3

Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment

Status: COMPLETED
Phase: N/A

Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)

Status: COMPLETED
Phase: PHASE2

Role of Nutrition and Maternal Genetics on the Programming of Development of Fetal Adipose Tissue

Status: UNKNOWN
Phase: N/A

Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential Hypertension

Status: COMPLETED
Phase: PHASE3

Adalimumab for the Management of Post-operative Crohn's Disease (CD)

Status: UNKNOWN
Phase: PHASE3

Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis

Status: TERMINATED
Phase: NA

Doppler Evaluation in RA Patients After Adalimumab.

Status: COMPLETED
Phase: PHASE4

Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTing Using the PRIME Platform (EXCELLENT-PRIME Registry)

Status: UNKNOWN
Phase: PHASE4

miRNAs and mRNAs in Psoriasis

Status: UNKNOWN
Phase: N/A

Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIV

Status: TERMINATED
Phase: PHASE4

Optimization of Treatment With Adalimumab (Humira)

Status: COMPLETED
Phase: N/A

Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants

Status: TERMINATED
Phase: PHASE3

A Blood Pressure Regulation and Stroke Risk Evaluation Study in Hypertensive Patients Treated With Eprosartan

Status: COMPLETED
Phase: N/A

Adalimumab-psoriasis and Small Bowel Lesions

Status: COMPLETED
Phase: PHASE4

A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects With Schizophrenia

Status: COMPLETED
Phase: PHASE1